Prelude Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,400
| Closed | -$120K | – | 1418 |
|
|
2024
Q4 | $120K | Sell |
16,400
-5,886
| -26% | -$43.2K | 0.01% | 945 |
|
|
2024
Q3 | $167K | Buy |
22,286
+10,632
| +91% | +$79.6K | 0.01% | 991 |
|
|
2024
Q2 | $104K | Sell |
11,654
-2,524
| -18% | -$22.5K | 0.01% | 1002 |
|
|
2024
Q1 | $144K | Sell |
14,178
-2,985
| -17% | -$30.2K | 0.01% | 1054 |
|
|
2023
Q4 | $173K | Buy |
17,163
+4,203
| +32% | +$42.3K | 0.01% | 843 |
|
|
2023
Q3 | $121K | Buy |
+12,960
| New | +$121K | 0.01% | 827 |
|
|
2022
Q2 | – | Sell |
-8,684
| Closed | -$223K | – | 1847 |
|
|
2022
Q1 | $223K | Buy |
+8,684
| New | +$223K | 0.01% | 947 |
|
|
2020
Q4 | – | Sell |
-1,532
| Closed | -$53K | – | 1580 |
|
|
2020
Q3 | $53K | Sell |
1,532
-1,668
| -52% | -$57.7K | ﹤0.01% | 846 |
|
|
2020
Q2 | $131K | Buy |
+3,200
| New | +$131K | 0.01% | 592 |
|